FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41137511000001107: Ambrisentan 10mg tablets (Cipla EU Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Nov 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1167551000001117 Ambrisentan 10mg tablets (Cipla EU Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1167561000001119 Ambrisentan 10mg tablets (Cipla EU Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ambrisentan 10mg tablets (Cipla EU Ltd) Is a Product containing precisely ambrisentan 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Cipla EU Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Cipla EU Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Cipla EU Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Cipla EU Ltd) Has specific active ingredient Ambrisentan true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Cipla EU Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Cipla EU Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ambrisentan 10mg tablets (Cipla EU Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ambrisentan 10mg tablets (Cipla EU Ltd) 30 tablet Has AMP True Ambrisentan 10mg tablets (Cipla EU Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start